Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase

Neuroscience Letters

Volumn 325, Issue 2, 2002, Pages 124-128

  Fornai, Francesco ^a   Carrì, Maria Teresa ^b,c   Ferri, Alberto ^d   Paolucci, Egle ^c   Prisco, Simona ^d   Bernardi, Giorgio ^c,d   Rotilio, Giuseppe ^c   Mercuri, Nicola Biagio ^d  

^a UNIVERSITY OF PISA   (Italy)

^b Centro di Neurobiologia Sperimentale Mondino Tor Vergata S Lucia   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

^d IRCCS FONDAZIONE SANTA LUCIA   (Italy)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Amyotrophic lateral sclerosis; Oxidative stress; Parkinson's disease; Reactive oxygen species; Superoxide dismutase

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; 5 HYDROXYINDOLEACETIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; HOMOVANILLIC ACID; NEUROTOXIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BLOOD LEVEL; DOPAMINERGIC NERVE CELL; ENZYME ACTIVITY; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; HUMANS; MICE; MICE, TRANSGENIC; MUTATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; SUBSTANTIA NIGRA; SUPEROXIDE DISMUTASE;

EID: 0037036216     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(02)00252-5     Document Type: Article

References (19)

1. Partial deficiency of manganese superoxide dismutase exacerbates a transgenic mouse model of amyotrophic lateral sclerosis
2. Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis
3. Metabolic dysfunction in familial, but not sporadic, amyotrophic lateral sclerosis
4. Calcineurin activity is regulated both by redox compounds and by mutant familial amyotrophic lateral sclerosis-superoxide dismutase
5. Effects of noradrenergic lesions on MPTP/MPP+ kinetics and MPTP-induced nigrostriatal dopamine depletions
6. Aberrant copper chemistry as a major mediator of oxidative stress in a human cellular model of amyotrophic lateral sclerosis
7. Aged mice are more sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment than young adults
8. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation
9. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis
10. Methamphetamine toxicity is attenuated in mice that overexpress human manganese superoxide dismutase
11. Subcellular distribution of superoxide dismutases in rat liver: Cu,Zn-SOD in mitochondria
12. Nigrostriatal dopaminergic function in familial amyotrophic lateral sclerosis patients with and without copper/zinc superoxide dismutase mutations
13. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
14. Oxidative processes and antioxidative defence mechanisms in the aging brain
15. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and methamphetamine in several strains of mice
16. Copper-dependent metabolism of Cu,Zn-superoxide dismutase in human K562 cells. Lack of specific transcriptional activation and accumulation of a partially inactivated enzyme
17. Serotonin content is elevated in the dopamine deficient striatum of the weaver mutant mouse
18. A fraction of yeast Cu,Zn-superoxide dismutase and its metallochaperone, CCS, localize to the intermembrane space of mitochondria. A physiological role for SOD1 in guarding against mitochondrial oxidative damage
19. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning